Annals of Behavioral Medicine

, Volume 19, Issue 3, pp 239–263 | Cite as

Compliance with cardiovascular disease prevention strategies: A review of the research

  • Lora E. Burke
  • Jacqueline M. Dunbar-Jacob
  • Martha N. Hill
Mini-Series: Prevention of Cardiovascular Disease

Abstract

The efficacy of cardiovascular risk-reduction programs has been established. However, the extent to which risk-reduction interventions are effective may depend on adherence. Non-compliance, or non-adherence, may occur with any of the recommended or prescribed regimens and may vary across the treatment course. Compliance problems, whether occurring early or late in the treatment course, are clinically significant, as adherence is one mediator of the clinical outcome. This article, which is based on a review of the empirical literature of the past 20 years, addresses compliance across four regimens of cardiovascular risk reduction: pharmacological therapy, exercise, nutrition, and smoking cessation. The criteria for inclusion of a study in this review were: (a) focus on cardiovascular disease risk reduction; (b) report of a quantitative measure of compliance behavior; and (c) use of a randomized controlled design. Forty-six studies meeting these criteria were identified. A variety of self-report, objective, and electronic measurement methods were used across these studies. The interventions employed diverse combinations of cognitive, educational, and behavioral strategies to improve compliance in an array of settings. The strategies demonstrated to be successful in improving compliance included behavioral skill training, self-monitoring, telephone/mail contact, self-efficacy enhancement, and external cognitive aids. A series of tables summarize the intervention strategies, compliance measures, and findings, as well as the interventions demonstrated to be successful. This review reflects the progress made over two decades in compliance measurement and research and further, advances made in the application of behavioral strategies to the promotion of cardiovascular risk reduction.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    National Heart Lung and Blood Institute:Morbidity & Mortality. Chartbook on Cardiovascular, Lung, and Blood Diseases. NIH, NHLBI, Office of Science and Technology, Bethesda, MD. 1994.Google Scholar
  2. (2).
    National Center for Health Statistics:Vital Statistics of the United States, 1968–1988 Washington, DC: U. S. Government Printing Office, 1992Google Scholar
  3. (3).
    Haskell WL, Alderman EL, Fair JM, et al: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease.Circulation. 1994,89:975–990.PubMedGoogle Scholar
  4. (4).
    Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease.Journal of the American Medical Association. 1984,251:351–364.Google Scholar
  5. (5).
    Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.Journal of the American Medical Association. 1984,251(3):365–374.Google Scholar
  6. (6).
    Shepherd J: The West of Scotland Coronary Prevention Study: A trial of cholesterol reduction in Scottish men.American Journal of Cardiology. 1995,76:113C-117C.PubMedGoogle Scholar
  7. (7).
    The Scandinavian Simvastatin Survival Study 4: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study, (4S).The Lancet. 1994,344:1383–1389.Google Scholar
  8. (8).
    Burke LE, Dunbar-Jacob J: Adherence to medication, diet, and activity recommendations: From assessment to maintenance.Journal of Cardiovascular Nursing. 1995,9:62–79.PubMedGoogle Scholar
  9. (9).
    Dunbar-Jacob J, Burke LE, Puczynski S: Clinical assessment and management of adherence to medical regimens. In Nicassio P, Smith T (eds),Managing Chronic Illness: A Biopsychosocial Perspective. Washington, DC: American Psychological Association, 1995, 313–349.Google Scholar
  10. (10).
    Oldridge NB: Compliance and dropout in cardiac exercise rehabilitation.Journal of Cardiac Rehabilitation. 1984,4:166–177.Google Scholar
  11. (11).
    Flack JM, Novikov SV, Ferrario CM: Benefits of adherence to antihypertensive drug therapy.The European Society of Cardiology. 1996,17(Suppl. A):16–20.Google Scholar
  12. (12).
    Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: A study of a United Kingdom population.British Medical Journal. 1995,311:293–295.PubMedGoogle Scholar
  13. (13).
    Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation. A meta-analysis.Journal of the American Medical Association. 1994,271:1940–1947.PubMedGoogle Scholar
  14. (14).
    Sherbourne CD, Ilays RD, Ordway L, DiMatteo MR, Kravitz RL: Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study.Journal of Behavioral Medicine. 1992,15(5):447–468.PubMedGoogle Scholar
  15. (15).
    Dubanoski JP: Preventive health behavior: A model of adherence prediction.Dissertation Abstracts International. 1988,48(10): 3152-B.Google Scholar
  16. (16).
    Dew MA, Roth LH, Thompson ME, Griffith BP: Medical compliance and its predictors in the first year after heart transplantation.Journal of Heart and Lung Transplantation. 1995,14:S70.Google Scholar
  17. (17).
    Leitha T, Staudenherz A, Bachmann B, Dudczak R: Effectiveness of coronary heart disease risk management in high-risk patients.Clinical Cardiology. 1994,17:123–130.PubMedGoogle Scholar
  18. (18).
    Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS: The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.Journal of the American Medical Association. 1990,263(12):1653–1657.PubMedGoogle Scholar
  19. (19).
    Ghali JK, Kadakia S, Cooper R, Ferlinz J: Precipitating factors leading to decompensation of heart failure.Archives of Internal Medicine. 1988,148:2013–2016.PubMedGoogle Scholar
  20. (20).
    De Geest S, Abraham I, Vanhaecke J: Clinical risk differentiation associated with subclinical noncompliance with cyclosporine-therapy: A cluster analytic study in heart transplant recipients. The Fifth International Transplant Nurses Society Symposium and General Assembly, New Orleans, LA: May 16–18, 1996.Google Scholar
  21. (21).
    Schron EB, Brooks MM, Gorkin L, et al: Relation of sociodemographic, clinical, and quality-of-life variables to adherence in the Cardiac Arrhythmia Suppression Trial.Cardiovascular Nursing. 1996,32(2):1–6.Google Scholar
  22. (22).
    Obias-Manno D, Friedmann E, Brooks MM, et al: Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST).Annals of Epidemiology. 1996,6(2):93–101.PubMedGoogle Scholar
  23. (23).
    Urquhart J: Patient compliance as an explanatory variable in four selected cardiovascular studies. In Cramer JA, Spilker B (eds),Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991.Google Scholar
  24. (24).
    Epstein LH, Koeske R, Wing RR: Adherence to exercise in obese children.Journal of Cardiac Rehabilitation. 1984,4:185–195.Google Scholar
  25. (25).
    Cramer JA, Scheyer RD, Mattson RH: Compliance declines between clinic visits.Archives of Internal Medicine. 1990,150: 1509–1510.PubMedGoogle Scholar
  26. (26).
    Dunbar-Jacob J, Dwyer K, Dunning EJ: Compliance with antihypertensive regimen: A review of the research in the 1980s.Annals of Behavioral Medicine. 1991,13(1):31–39.Google Scholar
  27. (27).
    Kruse WH: Compliance with treatment of hyperlipoproteinemia in medical practice and clinical trials. In Kramer JA, Spilker B (eds),Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991, 175–186.Google Scholar
  28. (28).
    Liacouras CA, Coates PM, Gallagher PR, Cortner JA: Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.Journal of Pediatrics. 1993,122(3):477–482.PubMedGoogle Scholar
  29. (29).
    Dunbar-Jacob J, Burke LE, Rohay JM, et al: Comparability of self-report, pill count, and electronically monitored adherence data.Controlled Clinical Trials. 1996,7(Suppl. 2):80S.Google Scholar
  30. (30).
    Saunders LD, Irwig LM, Gear JSS, Ramushu DL: A randomized controlled trial of compliance improving strategies in Soweto hypertensives.Medical Care. 1991,29(7):669–678.PubMedGoogle Scholar
  31. (31).
    Becker LA, Glanz K, Sobel E, et al: A randomized trial of special packaging of antihypertensive medications.Journal of Family Practice. 1986,22:357–361.PubMedGoogle Scholar
  32. (32).
    Friedman RH, Kazis LE, Jette A, et al: A telecommunications system for monitoring and counseling patients with hypertension.American Journal of Hypertension. 1996,9:285–292.PubMedGoogle Scholar
  33. (33).
    Raynor DK, Booth TG, Blenkinsopp A: Effects of computer generated reminder charts on patients' compliance with drug regimens.British Medical Journal. 1993,306:1158–1161.PubMedCrossRefGoogle Scholar
  34. (34).
    Park DC, Morrell RW, Frieske D, Kincaid D: Medication adherence behaviors in older adults: Effects of external cognitive supports.Psychology and Aging. 1992,7(2):252–256.PubMedGoogle Scholar
  35. (35).
    Morisky DE, Levine DM, Green LW, et al: Five-year blood pressure control and mortality following health education for hypertensive patients.American Journal of Public Health. 1983,73(2):153–162.PubMedGoogle Scholar
  36. (36).
    Webb P: Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients.Journal of Family Practice. 1980,10(6):1047–1055.PubMedGoogle Scholar
  37. (37).
    Nessman DG, Carnahan JE, Nugent CA: Increasing compliance: Patient-operated hypertension groups.Archives of Internal Medicine. 1980,140:1427–1430.PubMedGoogle Scholar
  38. (38).
    Skaer TL, Sclar DA, Markowski DJ, Won JKH: Effect of valueadded utilities on prescription refill compliance and healthcare expenditures for hypertension.Journal of Human Hypertension. 1993,7(5):515–518.PubMedGoogle Scholar
  39. (39).
    Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C: Effects of self-medication programme on knowledge of drugs and compliance with treatment in elderly patients.British Medical Journal. 1995,310:1229–1232.PubMedGoogle Scholar
  40. (40).
    Esposito L: The effects of medication education on adherence to medication regimens in an elderly population.Journal of Advanced Nursing. 1995,21:935–943.PubMedGoogle Scholar
  41. (41).
    Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB: Work-site treatment of hypertension by specially trained nurses—A controlled trial.The Lancet. 1979,2(8153):1175–1178.Google Scholar
  42. (42).
    Dunbar J, Knoke J: Prediction of medication adherence at one year and seven years: Behavioral and psychological factors. The Society for Clinical Trials Annual Conference. Montreal, Canada: 1986.Google Scholar
  43. (43).
    Leirer VO, Morrow DG, Pariante GM, Sheikh JI: Elders: Non-adherence, its assessment, and computer-assisted instruction for medication recall training.Journal of American Geriatric Society. 1988,36:877–884.Google Scholar
  44. (44).
    Kruse W, Weber E: Dynamics of drug regimen compliance—Its assessment by microprocessor-based monitoring.European Journal of Clinical Pharmacology. 1990,38:561–565.PubMedGoogle Scholar
  45. (45).
    Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is medication taken as prescribed? A novel assessment technique.Journal of the American Medical Association. 1989,261(22):3273–3277.PubMedGoogle Scholar
  46. (46).
    Andrade SE, Walker AM, Gottlieb LK, et al: Discontinuation of antihyperlipidemic drugs—Do rates reported in clinical trials reflect rates in primary care settings.New England Journal of Medicine. 1995,332(17):1125–1131.PubMedGoogle Scholar
  47. (47).
    Dishman RK: Compliance/adherence in health-related exercise.Health Psychology. 1982,1:237–267.Google Scholar
  48. (48).
    Todd IC, Ballantyne D: Effect of exercise training on the total ischaemic burden: An assessment by 24-hour ambulatory electrocardiographic monitoring.British Heart Journal. 1992,68:560–566.PubMedGoogle Scholar
  49. (49).
    Roman O, Gutierrez M, Luksic I, et al: Cardiac rehabilitation after acute myocardial infarction: 4-year controlled follow-up study.Cardiology. 1983,70:223–231.PubMedGoogle Scholar
  50. (50).
    Oldridge NB, Jones NL: Improving patient compliance in cardiac exercise rehabilitation. Effects of written agreement and self-monitoring.Journal of Cardiac Rehabilitation. 1983,3:257–262.Google Scholar
  51. (51).
    Daltroy LH: Improving cardiac patient adherence to exercise regimens: A clinical trial of health education.Journal of Cardiac Rehabilitation. 1985,5:40–49.Google Scholar
  52. (52).
    Hambrecht R, Niebauer J, Marburger C, et al: Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions.Journal of the American College of Cardiology. 1993,22(2):468–477.PubMedGoogle Scholar
  53. (53).
    Englblom E, Hietanen EK, Hamalainen H, et al: Exercise habits and physical performance during comprehensive rehabilitation after coronary artery bypass surgery.European Heart Journal. 1992,13:1053–1059.Google Scholar
  54. (54).
    King AC, Taylor CB, Haskell WL, DeBusk RF: Strategies for increasing early adherence to and long-term maintenance of home-based exercise training in healthy middle-aged men and women.American Journal of Cardiology. 1988,61:628–632.PubMedGoogle Scholar
  55. (55).
    Rogers F, Juneau M, Taylor CB, et al: Assessment by a microprocessor of adherence to home-based moderate-intensity exercise training in healthy, sedentary middle-aged men and women.American Journal of Cardiology. 1987,60:71–75.PubMedGoogle Scholar
  56. (56).
    Erdman RAM, Duivenvoorden HJ, Verhage F, Kazemier M, Hugenholtz PG: Predictability of beneficial effects in cardiac rehabilitation: A randomized clinical trial of psychosocial variables.Journal of Cardiopulmonary Rehabilitation. 1986,6:206–213.Google Scholar
  57. (57).
    DeBusk RF, Haskell WL, Miller NH, Berra K, Taylor CB: Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: A new model patient care.American Journal of Cardiology. 1985,55(4):251–257.PubMedGoogle Scholar
  58. (58).
    Schunk DH, Carbonari JP: Self-efficacy models. In Matarazzo JD, Weiss SM, Herd JA, Miller NE, Weiss SM (eds),Behavioral Health—A Handbook of Health Enhancement and Disease Prevention. New York: John Wiley and Sons, 1984, 230–247.Google Scholar
  59. (59).
    Glanz K: Dietitians' effectiveness and patient compliance with dietary regimens.Journal of the American Dietetic Association. 1979,75:631–636.PubMedGoogle Scholar
  60. (60).
    Mojonnier ML, Hall Y, Berkson DM, et al: Experience in changing food habits of hyperlipidemic men and women.Journal of the American Dietetic Association. 1980,77:140–148.PubMedGoogle Scholar
  61. (61).
    Karvetti R-L: Effects of nutrition education.Journal of the American Dietetic Association. 1981,79:660–667.PubMedGoogle Scholar
  62. (62).
    Mazzuca SA: Does patient education in chronic disease have therapeutic value.Journal of Chronic Diseases. 1982,35:521–529.PubMedGoogle Scholar
  63. (63).
    Mullen PD, Green LW, Persinger GS: Clinical trials of patient education for chronic conditions: A comparative meta-analysis of intervention types.Preventive Medicine. 1985,14:753–781.PubMedGoogle Scholar
  64. (64).
    Schuster PM, Waldron J: Gender differences in cardiac rehabilitation patients.Rehabilitation Nursing. 1991,16:248–253.PubMedGoogle Scholar
  65. (65).
    Yates BC: Gender differences in compliance behaviors and health preceptions of coronary bypass surgery patients.Progress in Cardiovascular Nursing. 1987,2:105–112.PubMedGoogle Scholar
  66. (66).
    Wing RR, Anglin K: Effectiveness of a behavioral weight control program for Blacks and Whites with NIDDM.Diabetes Care. 1996,19(5):409–413.PubMedGoogle Scholar
  67. (67).
    Glueck CJ, Gordon DJ, Nelson JJ, Davis CE, Tyroler HA: Dietary and other correlates of changes in total and low-density lipoprotein cholesterol in hypercholesterolemic men: The lipid research clinics primary prevention trial.American Journal of Clinical Nutrition. 1986,10:489–500.Google Scholar
  68. (68).
    Singh RB, Rastogi SS, Niaz MA, et al: Effect of fat-modified and fruit-and vegetable-enriched diets on blood lipids in the Indian Diet Heart Study.American Journal of Cardiology. 1992,70:869–874.PubMedGoogle Scholar
  69. (69).
    Barnard ND, Scherwitz LW, Ornish D: Adherence and acceptability of a low-fat, vegetarian diet among patients with cardiac disease.Journal of Cardiopulmonary Rehabilitation. 1992,12:423–431.CrossRefGoogle Scholar
  70. (70).
    Singh RB, Rastogi SS, Verma R, et al: Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: Results of one-year follow-up.British Medical Journal. 1992,304:1015–1019.PubMedGoogle Scholar
  71. (71).
    McCann BS, Follette WC, Driver JL, Brief DJ, Knopp RH: Self-efficacy and adherence in the dietary treatment of hyperlipidemia. The 96th Annual Convention of the American Psychological Association. Atlanta, GA: August, 1988.Google Scholar
  72. (72).
    Bovbjerg VE, McCann BS, Brief DJ, et al: Spouse support and long-term adherence to lipid-lowering diets.American Journal of Epidemiology. 1995,141(5):451–460.PubMedGoogle Scholar
  73. (73).
    Hentinen M, Kyngas H: Diabetic adolescents' compliance with health regimens and associated factors.International Journal of Nursing Studies. 1996,33(3):325–337.PubMedGoogle Scholar
  74. (74).
    Schmidt LE, Klover RV, Arfken CL, Delamater AM, Hobson D: Compliance with dietary prescriptions in children and adolescents with insulin-dependent diabetes mellitus.Journal of the American Dietetic Association. 1992,92(5):567–570.PubMedGoogle Scholar
  75. (75).
    Van Horn LV, Stumbo P, Moag-Stahlberg A, et al: The Dietary Intervention Study in Children (DISC): Dietary assessment methods for 8-to 10-year olds.Journal of the American Dietetic Association. 1993,93(12):1396–1403.PubMedGoogle Scholar
  76. (76).
    Sanchez-Bayle M, Gonzalez-Requejo A, Baeza J, et al: Diet therapy for hypercholesterolemia in children and adolescents.Archives of Pediatric and Adolescent Medicine. 1994,148:28–32.Google Scholar
  77. (77).
    Madsen J, Sallis JF, Rupp JW, et al: Relationship between self-monitoring of diet and exercise change and subsequent risk factor changes in children and adults.Journal of Patient Education and Counseling. 1993,21: 61–69.Google Scholar
  78. (78).
    Hanna KJ, Ewart CK, Kwiterovich PO: Child problem-solving competence, behavioral adjustment, and adhrence to lipid-lowering diet.Patient Education and Counseling. 1990,16: 119–131.PubMedGoogle Scholar
  79. (79).
    DISC Collaborative Research Group: Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: The Dietary Intervention Study in Children (DISC).Journal of the American Medical Association. 1995,273(18): 1429–1435.Google Scholar
  80. (80).
    Luepker RV, Perry CL, McKinlay SM, et al: Outcomes of a field trial to improve children's dietary patterns and physical activity. The Child and Adolescent Trial for Cardiovascular Health (CATCH).Journal of the American Medical Association. 1996,275(10): 768–776.PubMedGoogle Scholar
  81. (81).
    Lytle LA, Stone EJ, Nichaman MZ, et al: Changes in nutrient intakes of elementary school children following a school-based intervention. Results from the CATCH study.Preventive Medicine. 1996,25: 465–477.PubMedGoogle Scholar
  82. (82).
    Shannon BM, Tershakovec AM, Martel JK, et al: Reduction of elevated LDL-cholesterol levels of 4- to 10-year-old children through home-based dietary education.Pediatrics. 1994,94(6): 923–927.PubMedGoogle Scholar
  83. (83).
    Walter HJ, Hofman A, Vaughan RD, Wynder EL: Modification of risk factors for coronary heart disease: Five-year results of a school-based intervention trial.New England Journal of Medicine. 1988,318: 1093–1100.PubMedGoogle Scholar
  84. (84).
    Block G: Human dietary assessment: Methods and issues.Preventive Medicine. 1989,18: 643–660.Google Scholar
  85. (85).
    Block G: A review of validations of dietary assessment methods.American Journal of Epidemiology. 1982,115(4): 492–504.PubMedGoogle Scholar
  86. (86).
    Wylie-Rosett J, Wassertheil-Smoller S, Elmer P: Assessing dietary intake for patient education planning and evaluation.Patient Education and Counseling. 1990,15: 217–227.Google Scholar
  87. (87).
    Gibson RS: Measurement errors in dietary assessment. In Gibson RS (ed),Principles of Nutritional Assessment. New York: Oxford University Press, 1990.Google Scholar
  88. (88).
    Shwartz JL:Review and Evaluation of Smoking Cessation Methods: The United States and Canada, 1978–1985, NIH Publication No. 87-2940. Bethesda, MD: U.S. Department of Health and Human Services, 1987.Google Scholar
  89. (89).
    Burt A, Thornley P, Illingworth D, et al: Stopping smoking after myocardial infarction.The Lancet. 1974,1: 304–306.Google Scholar
  90. (90).
    Taylor CB, Houston-Miller N, Haskell WL, DeBusk RF: Smoking cessation after acute myocardial infarction: The effects of exercise training.Addictive Behaviors. 1988,13(4): 331–335.PubMedGoogle Scholar
  91. (91).
    Dale LC, Hurt RD, Offord KP, et al: High-dose nicotine patch therapy: Percentage of replacement and smoking cessation.Journal of the American Medical Association. 1995,274(17): 1353–1391.PubMedGoogle Scholar
  92. (92).
    Taylor CB, Houston-Miller N, Killen JD, DeBusk RF: Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention.Annals of Internal Medicine. 1990,113: 118–123.PubMedGoogle Scholar
  93. (93).
    Ockene JK, Kristeller J, Goldberg R, et al: Increasing the efficacy of physician-delivered smoking interventions: A randomized clinical trial.Journal of General Internal Medicine. 1991,6: 1–8.PubMedGoogle Scholar
  94. (94).
    Pederson LL: Compliance with physician advice to quit smoking: A review of the literature.Preventive Medicine. 1982,11: 71–84.PubMedGoogle Scholar
  95. (95).
    Jorenby DE, Smith SS, Fiore MC, et al: Varying nicotine patch dose and type of smoking cessatoin counseling.Journal of the American Medical Association. 1995,274(17): 1347–1352.PubMedGoogle Scholar
  96. (96).
    Cummings S, Richard R: Optimum cutoff points for biochemical validation of smoking status.American Journal of Public Health. 1988,78: 574–575.PubMedCrossRefGoogle Scholar
  97. (97).
    Condiotte MM, Lichtenstein E: Self-efficacy and relapse in smoking cessation programs.Journal of Consulting and Clinical Psychology. 1981,49(5): 648–658.PubMedGoogle Scholar
  98. (98).
    Ornish D, Brown SE, Scherwitz LW, et al: Can lifestyle changes reverse coronary heart disease?Lancet. 1990,336: 129–133.PubMedGoogle Scholar
  99. (99).
    Hughes GH, Hymowitz N, Ockene JK, Simon N, Vogt TM: The Multiple Risk Factor Intervention Trial (MRFIT): V. Intervention on smoking.Preventive Medicine. 1981,10: 476–500.PubMedGoogle Scholar
  100. (100).
    Ockene JK, Hymowitz N, Lagus J, Shaten BJ: Comparison of smoking behavior change for SI and UC study groups. MRFIT Research Group.Preventive Medicine. 1991,20(5): 564–573.PubMedGoogle Scholar
  101. (101).
    Caggiula AW, Christakis G, Ferrance M, et al: Intervention on blood lipids (for the MRFIT).Preventive Medicine. 1981,10: 443–475.PubMedGoogle Scholar
  102. (102).
    Simkin-Silverman L, Wing RR, Hansen DH, et al: Prevention of cardiovascular risk factor elevations in healthy premenopausal women.Preventive Medicine. 1995,24: 509–517.PubMedGoogle Scholar
  103. (103).
    Jakicic JM, Wing RR, Butler BA, Robertson RJ: Prescribing exercise in multiple short bouts versus one continuous bout: Effects on adherence, cardiorespiratory fitness, and weight loss in over-weight women.International Journal of Obesity. 1995,19: 893–901.PubMedGoogle Scholar
  104. (104).
    Swain MA, Steckel SB: Influencing adherence among hypertensives.Research in Nursing and Health. 1981,4: 213–222.PubMedGoogle Scholar
  105. (105).
    Kirscht JP, Kirscht JL, Rosenstock IM: A test of interventions to increase adherence to hypertensive medical regimens.Health Education Quarterly. 1981,8(3): 261–272.PubMedGoogle Scholar
  106. (106).
    Schuler G, Hambrecht R, Schlierf G, et al: Regular physical exercise and low-fat diet—Effects on progression of coronary artery disease.Circulation. 1992,86: 1–11.PubMedGoogle Scholar
  107. (107).
    Sivarajan ES, Newton KM, Almes MJ, et al: Limited effects of outpatient teaching and counseling after myocardial infarction: A controlled study.Heart and Lung. 1993,12(1): 65–73.Google Scholar
  108. (108).
    DeBusk RF, Miller NH, Superko HR, et al: A case-management system for coronary risk factor modification after acute myocardial infarction.Annals of Internal Medicine. 1994,120(9): 721–729.PubMedGoogle Scholar
  109. (109).
    Heller RF, Knapp JC, Valenti LA, Dobson AJ: Secondary prevention after acute myocardial infarction.American Journal of Cardiology. 1993,72: 759–762.PubMedGoogle Scholar
  110. (110).
    Kirkman MS, Weinberger M, Landsman PB, et al: A telephone-delivered intervention for patients with NIDDM.Diabetes Care. 1994,17(8): 840–846.PubMedGoogle Scholar
  111. (111).
    Hamalainen H, Luurila OJ, Kallio V, et al: Long-term reduction in sudden deaths after a multifactorial intervention programme in patients with myocardial infarction: 10-year results of a controlled investigation.European Heart Journal. 1989,10: 55–62.PubMedGoogle Scholar
  112. (112).
    Baker RC, Kirschenbaum DS: Self-monitoring may be necessary for successful weight control.Behavior Therapy. 1993,24: 377–394.Google Scholar
  113. (113).
    Grimm Jr. RH, Cohen JD, Smith M, et al: Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT): Six-year intervention results for men in special intervention and usual care groups.Archives of Internal Medicine. 1985,145: 1191–1199.PubMedGoogle Scholar
  114. (114).
    Dolocek TA, Milas NC, Van Horn LV, et al: A long-term nutrition intervention experience: Lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial.Journal of the American Dietetic Association. 1986,86: 752–758.Google Scholar
  115. (115).
    Cutler JA, Grandits GA, Grimm Jr. RH, et al: Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group.Preventive Medicine. 1991,20(2): 183–196.PubMedGoogle Scholar
  116. (116).
    Bouten CV, Westerterp KR, Verduin M, Janssen JD: Assessment of energy expenditure for physical activity using a triaxial accelerometer.Medicine and Science in Sports and Exercise. 1994,26(12): 1516–1523.PubMedGoogle Scholar
  117. (117).
    Connett JE, Stamler J: Responses of Black and White males to the special intervention program of the Multiple Risk Factor Intervention Trial.American Heart Journal. 1984,108(3 Pt. 2): 839–848.PubMedGoogle Scholar
  118. (118).
    Schuster PM, Wright C, Tomich P: Gender differences in the outcomes of participants in home program compared to those in structured cardiac rehabilitation programs.Rehabilitation Nursing. 1995,30(2): 93–101.Google Scholar
  119. (119).
    Epstein LH, Coleman KJ, Myers MD: Exercise in treating obesity in children and adolescents.Medicine and Science in Sports and Exercise. 1996,28(4): 428–435.PubMedGoogle Scholar
  120. (120).
    Wolfe S, Schirm V: Medication counseling for the elderly: Effects on knowledge and compliance after hospital discharge.Ceriatric Nursing. 1992,13: 134–139.Google Scholar
  121. (121).
    Lambert M, Lupien PJ, Gange C, et al: Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin.Pediatrics. 1996,97(5): 619–628.PubMedGoogle Scholar
  122. (122).
    Dunbar-Jacob J, Sereika S, Burke LE, et al: Can poor adherence be improved?Annals of Behavioral Medicine. 1996,17(Suppl.): S061.Google Scholar
  123. (123).
    Pambianco G, Wing RR, Robertson R: Accuracy and reliability of the Caltrac accelerometer for estimating energy expenditure.Medicine and Science in Sports and Exercise. 1990,22(6): 858–862.PubMedGoogle Scholar
  124. (124).
    Hermann C, Peters ML, Blanchard EB: Use of hand-held computers for symptom-monitoring: The case of chronic headache.Mind and Body Medicine. 1995,1(2): 59–71.Google Scholar
  125. (125).
    Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence.Medical Care. 1986,24(1): 67–74.PubMedGoogle Scholar
  126. (126).
    Hill MN, Berk RA: Psychological barriers to hypertension therapy adherence: Instrument development and preliminary psychometric evidence.Cardiovascular Nursing. 1995,31(6): 37–43.Google Scholar
  127. (127).
    Hickey ML, Owen SV, Froman RD: Instrument development: Cardiac diet and exercise self-efficacy.Nursing Research. 1992,41(6): 347–351.PubMedGoogle Scholar
  128. (128).
    Sallis JF, Pinski RB, Grossman RM, Patterson TL, Nader PR: The development of self-efficacy scales for health-related diet and exercise behaviors.Health Education Research. 1988,3(3): 283–292.Google Scholar
  129. (129).
    Burke LE, Ewart CK, Thompson PD, et al: Psychometric evaluation of the cholesterol-lowering diet self-efficacy scale.Circulation. 1995,92(Suppl. 8): 66.Google Scholar
  130. (130).
    McCann BS, Retzlaff BM, Dowdy AA, Walden CE, Knopp RH: Promoting adherence to low-fat, low-cholesterol diets: Review and recommendations.Journal of the American Dietetic Association. 1990,90: 1408–1414, 1417.PubMedGoogle Scholar
  131. (131).
    Glynn SM, Ruderman AJ: The development and validation of an eating self-efficacy scale.Cognitive Therapy and Research. 1986,10: 403.Google Scholar
  132. (132).
    Baer JS, Holt CS, Licktenstein E: Self-efficacy and smoking reexamined: Construct validity and clinical utility.Journal of Clinical and Consulting Psychology. 1986,54: 846–852.Google Scholar
  133. (133).
    De Geest S, Abraham I, Gemoets H, Evers G: Development of the long-term medication behaviour self-efficacy scale: Qualitative study for item development.Journal of Advance Nursing. 1994,19: 233–238.Google Scholar
  134. (134).
    Godin G: The effectiveness of interventions in modifying risk factors of individuals with coronary heart disease.Journal of Cardiopulmonary Rehabilitation. 1989,9: 223–236.Google Scholar
  135. (135).
    Ewart CK, Stewart KJ, Gilligan RE, Kelemen MH: Self-efficacy mediates strength gains during circuit weight training in men with coronary artery disease.Medicine and Science in Sports and Exercise. 1986,18(5): 531–540.PubMedGoogle Scholar
  136. (136).
    Ewart CK, Taylor CB: The effects of early postmyocardial infarction exercise testing on subsequent quality-of-life.Qualitative Life of Cardiovascular Care. 1985,1: 162–165.Google Scholar
  137. (137).
    Burke LE, Dunbar-Jacob J, Sereika S, Rohay JM: Outcome expectation vs self-efficacy as predictive of dietary adherence in cardiac rehabilitation patients.Annals of Behavioral Medicine. 1996,18(Suppl.): S088.Google Scholar
  138. (138).
    McCann BS, Bjovberg VE, Brief DJ, et al: Relationship of self-efficacy to cholesterol lowering and dietary change in hyperlipidemia.Annals of Behavioral Medicine. 1995,17(3): 221–226.Google Scholar
  139. (139).
    Wasson J, Gaudette C, Whaley F, Sauvigne A: Telephone care as a substitute for routine clinic follow-up.Journal of the American Medical Association. 1992,267(13): 1788–1793.PubMedGoogle Scholar
  140. (140).
    Bertera EM, Bertera RL: The cost-effectiveness of telephone vs clinic counseling for hypertensive patients: A pilot study.American Journal of Public Health. 1981,71(6): 626–629.PubMedGoogle Scholar
  141. (141).
    Dunbar J, Dunning EJ, Dwyer K: The development of compliance research in pediatric and adolescent populations: Two decades of research. In Krasnegor N, Johnson S, Epstein L, Jaffe S (eds),Monograph on Developmental Aspects of Health Compliance Behavior. Bethesda, MD: National Institute of Child Health and Human Development and the Bureau of Maternal and Child Health and Resource Development, 1993, 29–51.Google Scholar
  142. (142).
    Haynes RB, McKibbon KA, Kanani R: Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.The Lancet. 1996,348: 383–386.Google Scholar
  143. (143).
    Macharia WM, Leon GL, Rowe BH, Stephenson BJ, Haynes RB: An overview of interventions to improve compliance with appointment-keeping for medical services.Journal of the American Medical Association. 1992,267(13): 1813–1817.PubMedGoogle Scholar
  144. (144).
    Brownell KD, Cohen LR: Adherence to dietary regimens 1: An overview of research.Behavioral Medicine. 1995,20: 149–154.PubMedGoogle Scholar
  145. (145).
    Brownell KD, Cohen LR: Adherence to Dietary Regimens 2: Components of effective interventions.Behavioral Medicine. 1995,20: 155–164.PubMedGoogle Scholar
  146. (146).
    Dubbert PM: Exercise in behavioral medicine.Journal of Consulting and Clinical Psychology. 1992,60(4): 613–618.PubMedGoogle Scholar
  147. (147).
    Dishman RK (ed):Exercise Adherence: Its Impact on Public Health. Champaign, IL: Human Kinetics Books, 1988.Google Scholar
  148. (148).
    Meyers DG: Relative survival benefits of risk factor modifications.American Journal of Cardiology. 1996,77: 298–299.PubMedGoogle Scholar
  149. (149).
    Hill MN, Houston Miller N: Compliance Enhancement—A call for multidiscriplinary team approaches.Circulation. 1996,93: 4–6.PubMedGoogle Scholar
  150. (150).
    Smith SC: Risk-reduction therapy: The challenge to change.Circulation. 1996,93: 2205–2211.PubMedGoogle Scholar
  151. (151).
    Sackett DL, Haynes RB: Introduction. In Sackett DL, Haynes RB (eds),Compliance with Therapeutic Regimens. Baltimore, MD: The Johns Hopkins University Press, 1976, 1–5.Google Scholar

Copyright information

© The Society of Behavioral Medicine 1997

Authors and Affiliations

  • Lora E. Burke
    • 1
  • Jacqueline M. Dunbar-Jacob
    • 1
  • Martha N. Hill
    • 2
  1. 1.Department of PsychiatryUniversity of Pittsburgh, School of MedicinePittsburgh
  2. 2.The Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations